61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Viking Therapeutics Inc
Closed
Sector Healthcare
34.81 2.02
Overview
Share price change
24h
Min
32.5
Max
35.09
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +241.28 upside |
Next Earnings | 5 Feb 2025 |
|---|
News Sentiment
By Acuity
50%
50%
185 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
Viking Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Viking Therapeutics Inc Forecast
Price Target
By TipRanks
241.28% upside
12 Months Forecast
Average 112.18 USD 241.28%
High 164 USD
Low 74 USD
Based on 13 Wall Street analysts offering 12 month price targets forViking Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
185 / 392 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
$
